ENGIE and Mirova are proud to announce their strategic partnership in the biogas sector and the acquisition by the Mirova-Eurofideme 41
fund of a 50% stake into DANA GAZ, a company owning 9 operating biogas plants developed and owned by ENGIE. This transaction is the first step of a broader cooperation to expand the DANA GAZ asset portfolio.
In an unprecedented global sanitary crisis context, questioning the way supply chains work, ENGIE and Mirova believe that biogas will be key to building a circular economy, creating local jobs, and supporting agriculture, ultimately important to ensure food resilience and energy supply security.Mirova is investing through Mirova-Eurofideme 4, its ca. €860M fund dedicated to energy transition infrastructure projects, the largest of its kind in Europe
, and is taking a significant position into the biogas sector in France.
ENGIE, and its subsidiary ENGIE Bioz, is a leading biogas operator in France, active across the whole value chain from project development and construction, alongside local authorities, farmers and industrials, to project operation and energy sale.
« This major partnership in the biogas sector in France reflects our conviction that biogas will play an important role in advancing the energy transition. It will serve ENGIE’s goal to produce 5 TWh of biogas per annum by 2030
» indicated Rosaline Corinthien, Head of ENGIE France Renouvelables.
« We are pleased with this new cooperation with ENGIE, a longstanding partner of Mirova whom we have worked with on many wind, solar, and hydro projects across Europe. We believe in the potential of biogas to become a key contributor to the energy transition, as a truly decentralised source of energy with tangible local benefits
» added Raphaël Lance, Head of Energy Transition Funds at Mirova. ENGIE and Mirova previously together won the auction launched by EDP in Portugal and acquired a 1.7GW hydro portfolio in a €2.2bn transaction
. ENGIE will remain in charge of the operation and maintenance of the projects. For further reading:
1 Mirova Eurofideme 4 is a Société de Libre Partenariat (French limited partnership), with Mirova as Investment Management Company, is not subject to the approval of the French Market Authority and is closed to subscriptions.
About ENGIE BioZ
Since January 1, 2020, VOL-V Biomasse and ENGIE Biogaz have merged and become ENGIE BioZ, the ENGIE Group subsidiary in charge of biomethane projects in France. ENGIE BioZ initiates, develops, finances, builds and operates biomethane injection units in the French gas network, by anchoring it’s activity over the long term in the territories. The objective of an anaerobic digestion unit is to produce biomethane by collecting on the surrounding territory several types of organic matter. These can be of agricultural, industrial origin, or come from communities. ENGIE BioZ is one of the leaders in the production of renewable gas with 14 plants in operation.
Mirova is an investment manager dedicated to responsible investment. Through a conviction-driven investment approach, Mirova’s goal is to combine value creation over the long term with sustainable development. Mirova’s talents have been pioneers in many areas of sustainable finance. Their ambition is to keep innovating to propose the best tailored and most impactful solutions to their clients. Mirova has been actively investing into renewable energy infrastructure over the past 17 years, contributing to installing over 2GW through more than 180 onshore wind, solar, hydro, and biomass projects across Europe.
Affiliate of Natixis Investment Managers
French Public Limited liability company with board of Directors.
Share Capital: €8 813 860
Regulated by the Autorité des Marchés Financiers (AMF) under n° GP 02014.
RCS Paris n° 394 648 216
59 avenue Pierre Mendès France
Natixis Investment Managers
RCS Paris 453 952 681
Share Capital: €178 251 690
43 avenue Pierre Mendès France
This communication is for information only and is intended for investment service providers or other Professional Clients. The analyses and opinions referenced herein represent the subjective views of the author as referenced unless stated otherwise and are subject to change. There can be no assurance that developments will transpire as may be forecasted in this material.